VlasschaertC, et al.Proliferation of papers and preprints during the coronavirus disease 2019 pandemic: Progress or problems with peer review?Adv Chronic Kidney Dis2020; 27:418–426. doi: 10.1053/j.ackd.2020.08.003
VlasschaertC, Proliferation of papers and preprints during the coronavirus disease 2019 pandemic: Progress or problems with peer review? Adv Chronic Kidney Dis 2020; 27:418–426. doi: 10.1053/j.ackd.2020.08.00310.1053/j.ackd.2020.08.003)| false
MajumderMS, MandlKD. Early in the epidemic: Impact of preprints on global discourse about COVID-19 transmissibility. Lancet Glob Health 2020; 8:e627–e630. doi: 10.1016/S2214-109X(20)30113-310.1016/S2214-109X(20)30113-3)| false
1 Caitlyn Vlasschaert is a resident in the Department of Medicine, Queens University, Kingston, Ontario, Canada. Matthew B. Lanktree is with the Division of Nephrology, Department of Medicine, St. Joseph's Healthcare Hamilton, McMaster University, Hamilton, Ontario, Canada.
Preprinting—the practice of posting full manuscripts in public forums ahead of formal peer review—has been around for decades (1, 2). In the 1950s, manuscripts were circulated within close networks of colleagues to discuss new ideas and supporting data before publication. The 21st century adaptation of this concept has taken the form of preprint servers such as bioRxiv.org and medRxiv.org. Preprints are steadily garnering acceptance in medicine, especially in the progressive field of nephrology. Nearly all general medicine and nephrology journals currently accept articles already shared as a preprint (3,